The Chemours (NYSE:CC) will be issuing its quarterly earnings data after the market closes on Thursday, May 3rd. Analysts expect the company to announce earnings of $1.12 per share for the quarter. The Chemours has set its FY18 guidance at $4.95-5.60 EPS.
The Chemours (NYSE:CC) last issued its quarterly earnings results on Wednesday, February 14th. The specialty chemicals company reported $1.19 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.95 by $0.24. The Chemours had a return on equity of 115.54% and a net margin of 12.06%. The firm had revenue of $1.58 billion during the quarter, compared to analyst estimates of $1.55 billion. During the same period last year, the company earned $0.08 EPS. The Chemours’s quarterly revenue was up 19.1% compared to the same quarter last year. On average, analysts expect The Chemours to post $5 EPS for the current fiscal year and $6 EPS for the next fiscal year.
Shares of CC stock opened at $50.92 on Thursday. The Chemours has a 52-week low of $34.84 and a 52-week high of $58.08. The company has a debt-to-equity ratio of 4.74, a current ratio of 2.12 and a quick ratio of 1.55. The company has a market cap of $9,549.66, a P/E ratio of 13.33, a price-to-earnings-growth ratio of 0.63 and a beta of 2.95.
CC has been the subject of a number of research analyst reports. Zacks Investment Research raised The Chemours from a “hold” rating to a “strong-buy” rating and set a $58.00 price target for the company in a research note on Wednesday, February 21st. Morgan Stanley initiated coverage on The Chemours in a research note on Tuesday, January 30th. They set an “equal weight” rating and a $57.50 price target for the company. ValuEngine lowered The Chemours from a “buy” rating to a “hold” rating in a research note on Monday, April 2nd. BMO Capital Markets initiated coverage on The Chemours in a research note on Tuesday, March 27th. They set an “outperform” rating and a $68.00 price target for the company. Finally, TheStreet raised The Chemours from a “c+” rating to a “b-” rating in a research note on Monday, April 2nd. Four research analysts have rated the stock with a hold rating, eight have issued a buy rating and one has assigned a strong buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and an average target price of $59.50.
COPYRIGHT VIOLATION NOTICE: This piece was originally published by WKRB News and is owned by of WKRB News. If you are viewing this piece on another website, it was stolen and republished in violation of United States and international trademark and copyright law. The legal version of this piece can be accessed at https://www.wkrb13.com/2018/04/26/the-chemours-cc-set-to-announce-quarterly-earnings-on-thursday.html.
The Chemours Company Profile
The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Fluoroproducts, and Chemical Solutions. The Titanium Technologies segment manufactures and sells titanium dioxide under the Ti-Pure and BaiMax brands for various applications in architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride window profiles, laminate papers used for furniture and building materials, and coated papers and paperboards used for packaging.
Receive News & Ratings for The Chemours Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Chemours and related companies with MarketBeat.com's FREE daily email newsletter.